Loading Events

« All Events

  • This event has passed.

Meet the Johnson & Johnson Innovation Team

October 29, 2015 @ 2:00 pm - 4:00 pm

Johnson & Johnson Innovation recently announced the opening of JLABS @ Toronto, a partnership with University of Toronto, the Ontario Government and the MaRS Discovery District. Now is your chance to meet the team charged with a new kind of partnering program! Don’t miss this opportunity to learn more on the progress of this groundbreaking project. Join us for a chance to be one of the first to hear from Johnson & Johnson Innovation in person.

Program Overview:
Over the past few years, Innovators around the US have gotten a chance to know us at JLABS and that has given us an opportunity to interact with you and to think about what else you, the Innovator, need to get your science to the patient. Through our engagement, we continue to evolve in an effort to better meet the needs of the Innovator and ultimately the patient. It is because of you that Johnson & Johnson Innovation (J&J Innovation) created regional centers that host a team of science and transaction experts whose goal is to find high potential early-stage (pre-clinical proof-of-concept) innovation and form custom business solutions around it to help accelerate the science to the patient. The J&J Innovation team has broad deal-making capabilities with the flexibility to adapt the deal structures to the science.

Together our teams can provide you the best possible chance of taking your solution to the people who need it the most.

On October 29, hear from Johnson & Johnson Innovation Senior Directors of New Ventures Kuldeep Neote and Tom Luby. Kuldeep and Tom will provide an overview of J&J Innovation goals and mission, highlighting how J&J Innovation interacts with the entrepreneurial community through JLABS, JJDC, and other J&J Innovation initiatives. Don’t miss this opportunity to learn more on the progress of this groundbreaking project. Join us for a chance to be one of the first to hear from the Johnson & Johnson Innovation Center in person.

 

Spaces are limited, Register Today!

 

Agenda:
2:00pm | Registration opens, Lunch
2:30pm | Presentation and Q&A
4:00pm | Program closes

J&J Innovation Participating Representatives:
Kuldeep Neote | Senior Director, New Ventures, J&J Innovation
Tom Luby | Senior Director, New Ventures, J&J Innovation
Melinda Richter | Head, J&J Innovation, JLABS

 
Speakers’ Biographies:
Kuldeep Neote, Ph.D. | Senior Director, New Ventures, Johnson & Johnson Innovation, Boston
Kuldeep NeoteKuldeep is Senior Director of New Ventures at the Johnson & Johnson Innovation, Boston. He focuses primarily on the areas of Oncology and Immunology. A trained molecular biologist with an extensive background in drug discovery, Kuldeep has been focused on the areas of Immunology, Inflammation and Oncology and has a passion for implementing cutting edge scientific discoveries into practical drug discovery programs. Formerly, Kuldeep was Research Advisor/Director in Global External R&D at Eli Lilly. Prior to Eli Lilly, he was a Discovery Scientist at Pfizer, where he initiated the chemokine receptor drug discovery platform that led to the discovery and further development of several clinical candidates. Earlier in his career, Kuldeep also cloned one of the first chemokine receptors while at Genentech. Kuldeep earned his BSc. in Microbial and Cellular Biology at the University of Calgary, and a Ph.D. in Human and Molecule Genetics at the University of Toronto, where he was a major contributor in the understanding of the molecular basis of lysosomal storage diseases, in particular Tay Sachs and Sandhoff’s disease.
Connect with Kuldeep: Connect on LinkedIn
Thomas Luby, Ph.D., Senior Director, New Ventures, Johnson & Johnson Innovation, Boston
Thomas LubyTom is Senior Director of New Ventures at Johnson & Johnson Innovation, Boston. He focuses primarily on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson & Johnson Family of Companies, Tom was the Sr. Director of Research Ventures at Shire Human Genetic Therapies. In this position, Tom played a central role in the evaluation, diligence, and deal processes across a number of successful early-stage investments in the rare disease space. He was member of the BOD at Armagen Technologies, led the collaboration with Nimbus Discovery, and was instrumental in establishing and leading the alliance that Shire put in place with Atlas Venture. Prior to this, Tom held a variety of research and development roles in both start-up and mid-sized biotech. He has worked on multiple discovery through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His experience includes pre-clinical development, early-stage portfolio oversight, licensing, due diligence, company formation, alliance management, and key opinion leader outreach.
Tom received his BS in Biology from State University of New York, his Ph.D. in Immunology from Tufts University, and was a post-doctoral fellow in yeast genetics at Harvard School of Public Health.
Connect with Tom: Connect on LinkedIn

 

Melinda Richter, Head, Johnson & Johnson Innovation, JLABS
Melinda RichterAs Head of JLABS, Melinda fosters Johnson & Johnson’s external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a biotech company.
Prior to joining JLABS, Melinda was Founder and CEO of Prescience International, an award winning firm dedicated to accelerating research to the patient. Melinda founded Prescience after she had a medical emergency that left her questioning the efficiency and efficacy of the healthcare system. With the tenacity and resolve of a patient looking for a better solution, she set-out to create a better model, which now forms the basis for JLABS’ operational infrastructure. Prior to starting Prescience, Melinda held posts across a variety of functional areas with a global corporation, Nortel Networks, in locations such as Research Triangle Park, New York, Toronto, London, Hong Kong and Beijing before arriving in San Francisco. She also started, raised capital and did large corporate deals for several companies in both the life science and technology space. She holds a Bachelor of Commerce from the University of Saskatchewan in Canada and an MBA from INSEAD in France.
Connect with Melinda: Follow on Twitter   Connect on LinkedIn

Details

Date:
October 29, 2015
Time:
2:00 pm - 4:00 pm
Event Category: